Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3160
Selected: 0
NCT IDTitle
NCT02420795Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT01711944Online Problem Solving Skills Training
NCT05041127Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
NCT02419469Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
NCT00972101Infusion of Expanded Cord Blood T Cells
NCT04754412Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
NCT00410865Wild Type p53 Adenovirus for Oral Premalignancies
NCT02321501Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
NCT00508456Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
NCT01015222Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies
NCT03177681The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms
NCT01204788Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia
NCT05836870Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
NCT05335941A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
NCT00506857Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
NCT01160354Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
NCT00505245New Assessment System in Measuring Symptom Distress in Cancer Patients
NCT05056857Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
NCT07133425A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer
NCT01372540Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT04592250Financial Toxicity in Cancer Patients
NCT01333423Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)
NCT01782976Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
NCT02385110Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
NCT00038623Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
NCT008626804D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
NCT00255346Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
NCT007141038-Chloro-Adenosine in Chronic Lymphocytic Leukemia
NCT02500576Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma
NCT05041140Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
NCT01891968Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
NCT02529813CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
NCT04771520Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
NCT00349596A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)
NCT00667888A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
NCT00351988Effects of Cancer Symptoms on Caregivers
NCT02940496Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
NCT02722850Web-based Study for Cancer Survivors
NCT06263491Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
NCT01392170Pegasys in Patients With Chronic Myeloid Leukemia (CML)
NCT02703623Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
NCT03592459Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer
NCT04729725SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL
NCT00501345Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT02530515Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
NCT01590082Doxycycline, Temozolomide and Ipilimumab in Melanoma
NCT001026354-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00508235Quality of Friendships in Children With Neurofibromatosis
NCT06448026Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).
NCT03356821Perinatal Arterial Stroke Treated With Stromal Cells Intranasally